Skip to main content
. Author manuscript; available in PMC: 2025 Feb 1.
Published in final edited form as: FEBS J. 2022 Oct 12;291(4):632–645. doi: 10.1111/febs.16638

Table 1.

Analysis of published lipid profiles of brain tissue from FTD, PD and AD patients.

Disease (Reference) Region PE LPE PC LPC PS PI PA CL MAG DAG TAG Chol CE SE Cer HexCer GlcCer GlcSph SM GM1 GM2 GM3 GD3 GD2 GD1 GT3 GT1 BMP
FTD GRN [63] FL
FTD GRN [63] OL
FTD GRN [64] MFGC
PD [145] SN
PD [146] SN
PD [146] Putamen
PD [147] Putamen
PD [147] Cerebellum
PD [148] Caudate
PD [148] GP
PD [148] Putamen
PD [149] ACG
PD [149] Amygdala
PD [149] Visual cortex
Early pathology, no dementia [150] TL
Early AD [150] TL
Mild AD (Braak stage 3–4) [151] Cortex
Late AD [150] TL
Severe AD (Braak stage 5–6) [151] Cortex
AD [64] MFGC
AD [152] PFC
AD [152] EC
AD APOE e2 [119] RIPL
AD APOE e4 [119] RIPL

Orange cells = significantly enriched lipid. grey cells = no significant change from healthy subjects. Green cells = significantly depleted. FL, frontal lobe, OL, occipital lobe, MFGC, mid frontal gyrus cortex, ACC, anterior cingulate cortex, SN, substantia nigra, GP, globus pallidus, TL, temporal lobe, EC, entorhinal cortex, PFC, prefrontal cortex, RIPL, right inferior parietal lobule.